Catheter Precision, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Catheter Precision, Inc. (NYSE American: VTAK) on April 2, 2024. The report addresses a clerical correction regarding the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and does not contain new financial data.
Material Changes
There are no material changes to financial results or disclosures. The filing corrects a reference error in the "Consent of Independent Registered Public Accounting Firm" (Exhibit 23.1) originally filed with the Form 10-K. The original consent incorrectly cited Registration Statements on Form S-3 instead of Post-Effective Amendments to Form S-1. A revised consent dated April 2, 2024, has been filed to rectify these references.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. The Company explicitly states that the Revised Consent does not change any previously reported financial results or other disclosure contained in the Form 10-K.
Key Facts for Investor Verification
- The filing is a corrective measure for a clerical error in the accounting firm's consent letter attached to the 2023 Form 10-K.
- No financial performance data or operational updates are included in this report.
- Investors should refer to the Form 10-K filed on March 29, 2024, for the Company's audited financial results for the fiscal year ended December 31, 2023.
- The corrected Exhibit 23.1 is attached to this Form 8-K.